Form 4: Guardant Health CIO Acquires Shares Through RSU Vesting, Sells Portion for Tax Obligations

Guardant Health, Inc.'s Chief Information Officer, Kumud Kalia, reported the acquisition of common stock through the vesting of restricted stock units, with a portion subsequently sold to cover tax withholding obligations.

Summary

• Kumud Kalia, Chief Information Officer of Guardant Health, Inc. (GH), reported transactions related to her beneficial ownership of company securities.
• On June 15, 2025, Kalia acquired 637 shares of common stock through the vesting of restricted stock units (RSUs) at an exercise price of $0.
• Concurrently, 228 shares of common stock were disposed of at a price of $49.29 per share to satisfy tax withholding obligations related to the RSU vesting.
• Following these transactions, Kumud Kalia's direct beneficial ownership of common stock stands at 19,174 shares.
• The RSU award was granted on June 9, 2023, with 33% vesting on June 15, 2024, and the remaining 67% vesting in equal quarterly installments over the subsequent two-year period.
• After the reported transactions, Kalia beneficially owns 2,550 restricted stock units.

Sentiment

Score: 5

Explanation: Neutral. This is a routine insider transaction related to executive compensation and does not indicate a significant positive or negative shift in company fundamentals or outlook.

Positives

• The vesting of Restricted Stock Units (RSUs) indicates the realization of executive compensation, aligning management's interests with shareholder value.
• The acquisition of 637 shares at a $0 price reflects a non-cash gain from the RSU vesting, increasing the insider's direct equity stake.

Negatives

• A portion of the vested shares (228 shares) was sold back to the company at $49.29 per share to cover tax withholding obligations, reducing the net shares received by the insider.

Future Outlook

The remaining 67% of the Restricted Stock Unit award will vest in equal quarterly installments over the two-year period following June 15, 2024.

Industry Context

This is a routine insider transaction related to executive compensation and does not directly reflect broader industry trends or competitive dynamics. It is a standard mechanism for executives to realize value from equity awards.

Stakeholder Impact

• Shareholders: This is a routine transaction and is unlikely to have a material impact on the company's share price or long-term value. It reflects a standard component of executive compensation.
• Employees: No direct impact beyond the reporting person.

Next Steps

• Future quarterly installments of the Restricted Stock Unit award are expected to vest over the next two years.

Key Dates

Keywords

Guardant Health, GH, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Executive Compensation, Kumud Kalia, Stock Ownership, Tax Withholding